TIGIT and ovarian cancer: Taken together, the blockade of TIGIT induced a phenotypic repolarization defined by a reduction of M2-associated receptors and ultimately resulted in a significant augmentation of the anti-CD47-mediated ovarian cancer phagocytosis.